Crohn Disease study: MRI
Official title Concordance Between Inflammatory Activity Assessed by Enteric MRI With and Without Intestinal Distension Product in Patients With Ileal Crohn's Disease.
ClinicalTrials.gov ID: NCT07471438
What this study is testing
- What it's testing
- Crohn's disease (CD) is a chronic inflammatory bowel disease (IBD) that can significantly impair patients' quality of life.
This is a blinded study.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Adults
You may be able to join if
- Patients with Crohn's disease according to European recommendations (ECCO) ≥ 18 years of age
- With known or suspected ileal ± colonic involvement
- Requiring reassessment of disease inflammatory activity according to the clinician
- Able to give informed consent to participate in the research.
- Affiliation with a Social Security scheme
You likely can't join if
- Isolated colonic Crohn's disease
- Resection \> 1 m of small intestine
- Severe obstructive symptoms defined according to CDOS (Crohn's disease obstructive symptoms score)
- Uncontrolled intra-abdominal abscess
- Isolated anoperineal lesions
- Prevention of postoperative endoscopic recurrence
See the full eligibility criteria
- Patients with Crohn's disease according to European recommendations (ECCO) ≥ 18 years of age
- With known or suspected ileal ± colonic involvement
- Requiring reassessment of disease inflammatory activity according to the clinician
- Able to give informed consent to participate in the research.
- Affiliation with a Social Security scheme
- Agreeing to undergo two MRIs in the same week
- Isolated colonic Crohn's disease
- Resection \> 1 m of small intestine
- Severe obstructive symptoms defined according to CDOS (Crohn's disease obstructive symptoms score)
- Uncontrolled intra-abdominal abscess
- Isolated anoperineal lesions
- Prevention of postoperative endoscopic recurrence
- Temporary or permanent stoma
- Total colectomy
- Contraindication to MRI
- Pregnant or breastfeeding women
- Protected adults (under guardianship, trusteeship, family authorization, future protection mandate, with representation relating to the person)
The study team makes the final eligibility decision.
Where it is enrolling
- Amiens, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, not specified. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Amiens, France. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.